Eric Mayer, MMB MBA – Chief Executive Officer
Mr. Mayer was appointed CEO in 2015, and previously served as the Company’s VP of Business Development from 2013-2015. Prior to EDP Biotech, Eric Mayer had directed business development at BioPet Vet Lab and developed veterinary diagnostic products at AAD, Inc. His experience in biomedical/pharmaceutical start-ups include Metabolon, Inc. and Cirrus Pharmaceuticals. He received his Bachelor’s in Biochemistry from UNC-Chapel Hill, and his Master’s of Microbial Biotechnology (MMB) and Master’s of Business Administration (MBA) from North Carolina State University.
Jason Liggett, Ph.D. – Lead Scientist
Jason Liggett, a Knoxville native, is co-inventor of COLOPLEX and comes to EDP Biotech with experiences in both clinical and research sciences related to colorectal cancer. His doctorate studies in Comparative and Experimental Medicine focused on molecular mechanisms of non-steroidal anti-inflammatory drugs (NSAIDs) and their effects in human colorectal cancer. He worked in translational medicine in the core laboratory at University of Tennessee Medical Center and as a senior IVD scientist in developing colorectal cancer tests for more than a decade. He is the primary/secondary author on more than 20 publicans, presentations and awards. He holds a Bachelor’s in Medical Technology and a Ph.D. in Comparative and Experimental Medicine from the University of Tennessee.
Michael Weis, BSMT(ASCP) – Clinical Lab Supervisor
Michael Weis has nearly 30 years of experience supervising clinical laboratories and performing clinical tests. Michael is BSMT(ASCP) certified since 1992 with supervisory experience and licensure in every clinical size and modality, with unique professional abilities in Process Improvement, Standardization, and Efficiency. Michael’s clinical experiences include Tennova Physicians Regional Medical Center, Siemens Healthcare Diagnostics, and University of Alabama at Birmingham Hospital Laboratory.
Jim Fetzer – Quality Assurance Manager
Jim Fetzer comes to EDP Biotech with 20 years of experience implementing effective ISO Quality Management Systems and compliant FDA/Global regulatory requirements. Prior to EDP Biotech, Jim Fetzer supervised the quality department at Scapa Healthcare that included clients such as GlaxoSmithKline, Smith & Nephew, and ConvaTec. His tenure in quality assurance at prior corporations such as Northrop Grumman and DENSO North America has presented beneficial continuous improvements for EDP Biotech. Jim holds an Associates of Science in General Studies from Pellissippi State Community College and is a certified ISO 13485:2016 Lead Auditor (TPECS).
Craig Fernandes, MBA – Commercial Sales Director
Craig Fernandes is an accomplished healthcare professional with a 20+ year history of success and experience developing business partnerships, pioneering new market expansion, and implementing sustainable growth strategies. Highly skilled at transitioning corporate direction and strategy to move from commodity to value based products. Prior to EDP Biotech, Craig founded and ran CF Healthcare Consulting, and was senior director at DeRoyal Industries. He has his MBA from Babson College and a BS in Business Administration from Lemoyne College.
Anton Jansen, MS – International Sales Consultant
Anton Jansen has 25 years of experience in the global medical device healthcare industry with demonstrated success in developing new international markets for innovative diagnostic products to include the PLAC Test for diaDexus; respiratory and sleep apnea devices for Tyco Healthcare (now Covidien); and Lipid Point of Care devices for Cholestech. He has built strong relationships with key opinion leaders with expertise in organizing clinical studies and seminars at major conferences. He has a B.S. in Chemistry and M.S. in Biochemistry from The Netherlands. Anton moved in 1995 to the US and is fluent in Dutch and German.